PA
| |
PERCEPTIVE ADVISORS LLC13F | |
PERCEPTIVE ADVISORS LLC | |
Last update 2025-02-16 | 99 Stocks (21 new) |
Value $3.63 Bil | Turnover 8 % |
PERCEPTIVE ADVISORS LLC Top Holdings of 2024-12-31
View Full List
Ticker | | Company | Shares | Value ($1000) | Shares Change % | Weighting % | Trade Impact % | % of Shares outstanding | 3M Change % | YTD Change % | Market Cap $Mil | Industry |
---|---|---|---|---|---|---|---|---|---|---|---|---|
VRNA | Verona Pharma PLC | 6,392,106 | 296,849.4 | +1.21% | 8.180 | +0.10% | 7.810 | +13.27% | +46.97% | 5,810.7 | Biotechnology | |
ACLX | Arcellx Inc | 3,478,888 | 266,795.9 | -10.54% | 7.350 | -0.72% | 6.430 | -16.80% | -27.41% | 3,065.9 | Biotechnology | |
FOLD | Amicus Therapeutics Inc | 24,245,952 | 228,396.9 | -13.58% | 6.290 | -0.86% | 8.110 | -37.36% | -35.83% | 1,861.4 | Biotechnology | |
RYTM | Rhythm Pharmaceuticals Inc | 3,680,473 | 206,032.9 | +3.38% | 5.680 | +0.19% | 5.990 | +1.89% | +7.72% | 3,835.0 | Biotechnology | |
NUVL | Nuvalent Inc | 2,619,977 | 205,091.8 | -12.06% | 5.650 | -0.78% | 3.690 | -15.24% | -7.23% | 5,213.9 | Biotechnology | |
IOVA | Iovance Biotherapeutics Inc | 22,112,266 | 163,630.8 | -16.93% | 4.510 | -0.90% | 7.260 | -42.79% | -56.01% | 1,087.0 | Biotechnology | |
PCVX | Vaxcyte Inc | 1,718,417 | 140,669.6 | -15.25% | 3.880 | -0.75% | 1.380 | -63.19% | -60.69% | 4,151.2 | Biotechnology | |
ITCI | Intra-Cellular Therapies Inc | 1,288,328 | 107,601.2 | -20.58% | 2.970 | -0.52% | 1.210 | +57.89% | +57.89% | 14,047.0 | Drug Manufacturers | |
CNTA | Centessa Pharmaceuticals PLC | 6,349,220 | 106,349.4 | +1.07% | 2.930 | +0.03% | 4.820 | -33.79% | -24.78% | 1,683.3 | Biotechnology | |
PRAX | Praxis Precision Medicines Inc | 1,329,735 | 102,336.4 | +14.23% | 2.820 | +0.35% | 7.130 | -55.54% | -49.81% | 786.9 | Biotechnology |
PERCEPTIVE ADVISORS LLC's Historical Top Holdings Breakdowns
PERCEPTIVE ADVISORS LLC's Top Stock Picks
View Full List
Ticker | | Company | Date | Action | Impact % | Price Range | Price | Price Change from Avrg% | Comment | Current Shares | Share Change |
---|---|---|---|---|---|---|---|---|---|---|---|
SLNO | Soleno Therapeutics Inc | 2024-12-31 | Reduce | -1.82% | 44.77 ($51.85) 59.18 | $78.94 | 52.24% | Reduce -53.17% | 1,501,040 | -1,703,936 | |
BHVN | Biohaven Ltd | 2024-12-31 | Sold Out | -1.57% | 35.34 ($46.63) 53.74 | $20.32 | -56.42% | Sold Out | 0 | -1,485,232 | |
APLT | Applied Therapeutics Inc | 2024-12-31 | Reduce | -1.29% | 0.82 ($6.23) 10.24 | $0.41 | -93.48% | Reduce -89.26% | 860,000 | -7,145,000 | |
JANX | Janux Therapeutics Inc | 2024-12-31 | New Buy | +1.21% | 40.18 ($53.03) 66.84 | $26.13 | -50.73% | New holding | 817,895 | 817,895 | |
APGE | Apogee Therapeutics Inc | 2024-12-31 | Reduce | -1.20% | 42.86 ($50.9) 61.12 | $37.62 | -26.10% | Reduce -48.03% | 1,047,232 | -967,775 | |
VKTX | Viking Therapeutics Inc | 2024-12-31 | Reduce | -0.94% | 38.28 ($56.94) 78.03 | $28.25 | -50.38% | Reduce -41.42% | 995,894 | -704,093 | |
IOVA | Iovance Biotherapeutics Inc | 2024-12-31 | Reduce | -0.90% | 7.17 ($9.27) 12.28 | $3.25 | -64.94% | Reduce -16.93% | 22,112,266 | -4,505,443 | |
FOLD | Amicus Therapeutics Inc | 2024-12-31 | Reduce | -0.86% | 9.36 ($10.39) 12.01 | $6.04 | -41.82% | Reduce -13.58% | 24,245,952 | -3,811,504 | |
NUVL | Nuvalent Inc | 2024-12-31 | Reduce | -0.78% | 77.87 ($93.23) 104.93 | $72.82 | -21.89% | Reduce -12.06% | 2,619,977 | -359,258 | |
TARS | Tarsus Pharmaceuticals Inc | 2024-12-31 | Reduce | -0.77% | 32.27 ($45.63) 55.37 | $46.92 | 2.84% | Reduce -85.6% | 186,662 | -1,109,754 |
PERCEPTIVE ADVISORS LLC Total Holding History ($B)
PERCEPTIVE ADVISORS LLC's Asset Allocation
PERCEPTIVE ADVISORS LLC Past Portfolios
Portfolio Date | Number of Stocks | New Stocks | Total Value ($Mil) | Q/Q Turnover |
---|---|---|---|---|
Top Ranked Articles
- 1
PERCEPTIVE ADVISORS LLC's Hypothetical Growth since 2024-12-31
PERCEPTIVE ADVISORS LLC's Yearly Returns
Year | Portfolio % | % | Excess Gain % |
---|
PERCEPTIVE ADVISORS LLC's Holdings Heat Map
Size field:
PERCEPTIVE ADVISORS LLC's Holdings Bubble Chart
PERCEPTIVE ADVISORS LLC News
- 1